Kristi Jones, NexImmune CEO

Sev­er­al biotechs con­tin­ue trend of lay­offs, pipeline culls as third quar­ter re­ports roll in

Over the past sev­er­al weeks, small and large com­pa­nies alike have re­sort­ed to cost-cut­ting mea­sures, bring­ing the ham­mer down on em­ploy­ees or cut­ting pieces from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.